Considering that several LNK mutations are associated with myeloproliferative neoplasms [123], we first scrutinized publicly available data in the cBioPortal for Cancer Genomics [141,142], searching for mutations in breast cancer samples. The gene discussed is SH2B3; the disease is myeloproliferative disorder.